Upregulation of topoisomerase IIα expression in advanced gallbladder carcinoma: a potential chemotherapeutic target View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-01-17

AUTHORS

Mitsutsune Washiro, Masayuki Ohtsuka, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Takashi Sugimoto, Naohiko Seki, Masaru Miyazaki

ABSTRACT

PurposeThe lack of treatment options other than surgical resection results in unfavourable prognosis of advanced gallbladder carcinoma. The aim of this study was to identify cancer-specific cellular targets that would form the basis for some therapeutic approaches for this disease.MethodsTwelve advanced gallbladder carcinoma tissue samples and three samples of normal gallbladder epithelium were screened to identify differentially expressed genes by DNA microarray analysis. The results obtained were validated in an independent sample set by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR). Among the genes picked-up, one molecule, topoisomerase IIα (TOPO IIα), was further assessed immunohistochemically as a potential chemotherapeutic target, and the growth inhibitory effects of etoposide, doxorubicin and idarubicin, representative TOPO IIα inhibitors, on two different gallbladder carcinoma cell lines were compared with that of gemcitabine and 5-fulorouracil.ResultsFive upregulated genes were identified: four cell cycle-related genes (TOPO IIα, cyclin B2, CDC28 protein kinase regulatory subunit 2, ubiquitin-conjugating enzyme E2C) and a metabolism-related gene (γ-glutamyl hydrolase). Immunohistochemically, TOPO IIα was expressed in gallbladder cancer cells, and 16 of 35 cases (46%) had strong TOPO IIα expression defined as having a labeling index of >50%. In in vitro growth inhibition assay, etoposide, as well as doxorubicin and idarubicin, was the most effective for OCUG-1 cells that had strong TOPO IIα expression, while gemicitabine was the most effective for NOZ cells with weak TOPO IIα expression. Etoposide induced apoptosis of OCUG-1 cells.ConclusionsTOPO IIα might be an effective chemotherapeutic target in advanced gallbladder carcinoma, especially when it is expressed strongly. More... »

PAGES

793-801

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00432-007-0348-0

DOI

http://dx.doi.org/10.1007/s00432-007-0348-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007809517

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18204862


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blotting, Western", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Topoisomerases, Type II", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gallbladder Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Profiling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Idarubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligonucleotide Array Sequence Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reverse Transcriptase Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Up-Regulation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Washiro", 
        "givenName": "Mitsutsune", 
        "id": "sg:person.0777733357.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777733357.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohtsuka", 
        "givenName": "Masayuki", 
        "id": "sg:person.0653527253.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653527253.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimura", 
        "givenName": "Fumio", 
        "id": "sg:person.01127754745.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127754745.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimizu", 
        "givenName": "Hiroaki", 
        "id": "sg:person.01103413111.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103413111.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshidome", 
        "givenName": "Hiroyuki", 
        "id": "sg:person.016423226454.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016423226454.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Life Science Products, Hitachi Software Engineering Co. Ltd., 1-1-43 Suehiro, Tsurumi-ku, 230-0045, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417547.4", 
          "name": [
            "Department of Life Science Products, Hitachi Software Engineering Co. Ltd., 1-1-43 Suehiro, Tsurumi-ku, 230-0045, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugimoto", 
        "givenName": "Takashi", 
        "id": "sg:person.01106240505.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106240505.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seki", 
        "givenName": "Naohiko", 
        "id": "sg:person.0673163715.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673163715.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyazaki", 
        "givenName": "Masaru", 
        "id": "sg:person.0773025611.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773025611.35"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10495-005-1898-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048856830", 
          "https://doi.org/10.1007/s10495-005-1898-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s005340100021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043249581", 
          "https://doi.org/10.1007/s005340100021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601185", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025939800", 
          "https://doi.org/10.1038/sj.bjc.6601185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1205020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020268233", 
          "https://doi.org/10.1038/sj.onc.1205020"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-01-17", 
    "datePublishedReg": "2008-01-17", 
    "description": "PurposeThe lack of treatment options other than surgical resection results in unfavourable prognosis of advanced gallbladder carcinoma. The aim of this study was to identify cancer-specific cellular targets that would form the basis for some therapeutic approaches for this disease.MethodsTwelve advanced gallbladder carcinoma tissue samples and three samples of normal gallbladder epithelium were screened to identify differentially expressed genes by DNA microarray analysis. The results obtained were validated in an independent sample set by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR). Among the genes picked-up, one molecule, topoisomerase II\u03b1 (TOPO II\u03b1), was further assessed immunohistochemically as a potential chemotherapeutic target, and the growth inhibitory effects of etoposide, doxorubicin and idarubicin, representative TOPO II\u03b1 inhibitors, on two different gallbladder carcinoma cell lines were compared with that of gemcitabine and 5-fulorouracil.ResultsFive upregulated genes were identified: four cell cycle-related genes (TOPO II\u03b1, cyclin B2, CDC28 protein kinase regulatory subunit 2, ubiquitin-conjugating enzyme E2C) and a metabolism-related gene (\u03b3-glutamyl hydrolase). Immunohistochemically, TOPO II\u03b1 was expressed in gallbladder cancer cells, and 16 of 35 cases (46%) had strong TOPO II\u03b1 expression defined as having a labeling index of >50%. In in vitro growth inhibition assay, etoposide, as well as doxorubicin and idarubicin, was the most effective for OCUG-1 cells that had strong TOPO II\u03b1 expression, while gemicitabine was the most effective for NOZ cells with weak TOPO II\u03b1 expression. Etoposide induced apoptosis of OCUG-1 cells.ConclusionsTOPO II\u03b1 might be an effective chemotherapeutic target in advanced gallbladder carcinoma, especially when it is expressed strongly.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00432-007-0348-0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "134"
      }
    ], 
    "keywords": [
      "potential chemotherapeutic target", 
      "chemotherapeutic target", 
      "Topo II\u03b1 expression", 
      "advanced gallbladder carcinoma", 
      "cell cycle-related genes", 
      "real-time reverse transcription-polymerase chain reaction", 
      "DNA microarray analysis", 
      "cycle-related genes", 
      "II\u03b1 expression", 
      "gallbladder carcinoma", 
      "metabolism-related genes", 
      "gallbladder cancer cells", 
      "upregulated genes", 
      "microarray analysis", 
      "cellular targets", 
      "Topo II\u03b1 inhibitors", 
      "gallbladder carcinoma cell line", 
      "genes", 
      "surgical resection results", 
      "carcinoma cell lines", 
      "topoisomerase II\u03b1", 
      "induced apoptosis", 
      "quantitative real-time reverse transcription-polymerase chain reaction", 
      "reverse transcription-polymerase chain reaction", 
      "topoisomerase II\u03b1 expression", 
      "transcription-polymerase chain reaction", 
      "NOZ cells", 
      "carcinoma tissue samples", 
      "II\u03b1 inhibitors", 
      "cell lines", 
      "cancer cells", 
      "growth inhibitory effects", 
      "Topo II\u03b1", 
      "II\u03b1", 
      "normal gallbladder epithelium", 
      "growth inhibition", 
      "expression", 
      "unfavourable prognosis", 
      "treatment options", 
      "resection results", 
      "therapeutic approaches", 
      "cells", 
      "labeling index", 
      "carcinoma", 
      "inhibitory effect", 
      "tissue samples", 
      "chain reaction", 
      "target", 
      "idarubicin", 
      "gallbladder epithelium", 
      "apoptosis", 
      "doxorubicin", 
      "upregulation", 
      "gemicitabine", 
      "prognosis", 
      "independent samples", 
      "gemcitabine", 
      "inhibitors", 
      "etoposide", 
      "disease", 
      "epithelium", 
      "inhibition", 
      "molecules", 
      "lines", 
      "options", 
      "aim", 
      "samples", 
      "index", 
      "cases", 
      "study", 
      "basis", 
      "lack", 
      "effect", 
      "analysis", 
      "results", 
      "reaction", 
      "approach"
    ], 
    "name": "Upregulation of topoisomerase II\u03b1 expression in advanced gallbladder carcinoma: a potential chemotherapeutic target", 
    "pagination": "793-801", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007809517"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00432-007-0348-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18204862"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00432-007-0348-0", 
      "https://app.dimensions.ai/details/publication/pub.1007809517"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_475.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00432-007-0348-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00432-007-0348-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00432-007-0348-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00432-007-0348-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00432-007-0348-0'


 

This table displays all metadata directly associated to this object as RDF triples.

308 TRIPLES      21 PREDICATES      131 URIs      119 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00432-007-0348-0 schema:about N0cdb6efdeef54dcb90839b3e927bcccd
2 N1fb39f914c194e7fbba662e2ada3c0ff
3 N2100a738124c40a8bb19c1cef7ea58d2
4 N339f9fcc3af64c44830d301341231a67
5 N482953226bb1495da462e9b58f3e5b2b
6 N4942ca52192f44c5903154749397cfad
7 N7100ec9c17d249e78706d6e741974027
8 N77d81251552c4412b335c899032956a9
9 N7b0cb2f6b7254ae8ae8f3339c6390249
10 N9209d012e3f44c8482ceb377bdbe563a
11 N9830dccc6d6149f89b8ae2e465156625
12 N9a5c47ad027748af8a5f55e02247178b
13 Na660a6d6a6d04bb49b7d46b2721372fa
14 Na7b41ea35a49445cb0543e23c03407d3
15 Ncb6e4b40353f417e8c40f5a2389bf162
16 Nd035cb41fc664b628b0916debfc79005
17 Nd2cbf7cc894045439ab057d0b6a34cec
18 Nd60cf22803494a48905e066fffdb2924
19 Nd974780a381f49e8a42f800cdd7c0ddb
20 Ndc33932dfc0844b3aaf701eab3137df6
21 Ne867ca78eeb049578b44c76581a47865
22 Nef9fc8e3f73f40319162d8d5a748da0c
23 Nf14ce050409a4ae4843abe7eff2d37a3
24 Nf69060a32a82453a8aa3adc36b2b5922
25 Nf8b8603ce732486dbc9845d327c35a47
26 anzsrc-for:11
27 anzsrc-for:1112
28 schema:author N8f07a3d5e52d493c8db913b9fe4120de
29 schema:citation sg:pub.10.1007/s005340100021
30 sg:pub.10.1007/s10495-005-1898-8
31 sg:pub.10.1038/sj.bjc.6601185
32 sg:pub.10.1038/sj.onc.1205020
33 schema:datePublished 2008-01-17
34 schema:datePublishedReg 2008-01-17
35 schema:description PurposeThe lack of treatment options other than surgical resection results in unfavourable prognosis of advanced gallbladder carcinoma. The aim of this study was to identify cancer-specific cellular targets that would form the basis for some therapeutic approaches for this disease.MethodsTwelve advanced gallbladder carcinoma tissue samples and three samples of normal gallbladder epithelium were screened to identify differentially expressed genes by DNA microarray analysis. The results obtained were validated in an independent sample set by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR). Among the genes picked-up, one molecule, topoisomerase IIα (TOPO IIα), was further assessed immunohistochemically as a potential chemotherapeutic target, and the growth inhibitory effects of etoposide, doxorubicin and idarubicin, representative TOPO IIα inhibitors, on two different gallbladder carcinoma cell lines were compared with that of gemcitabine and 5-fulorouracil.ResultsFive upregulated genes were identified: four cell cycle-related genes (TOPO IIα, cyclin B2, CDC28 protein kinase regulatory subunit 2, ubiquitin-conjugating enzyme E2C) and a metabolism-related gene (γ-glutamyl hydrolase). Immunohistochemically, TOPO IIα was expressed in gallbladder cancer cells, and 16 of 35 cases (46%) had strong TOPO IIα expression defined as having a labeling index of >50%. In in vitro growth inhibition assay, etoposide, as well as doxorubicin and idarubicin, was the most effective for OCUG-1 cells that had strong TOPO IIα expression, while gemicitabine was the most effective for NOZ cells with weak TOPO IIα expression. Etoposide induced apoptosis of OCUG-1 cells.ConclusionsTOPO IIα might be an effective chemotherapeutic target in advanced gallbladder carcinoma, especially when it is expressed strongly.
36 schema:genre article
37 schema:isAccessibleForFree false
38 schema:isPartOf N481212cb83304d679cc8f11e514f0489
39 N5221e52cd56b4c57836034a438e07ea5
40 sg:journal.1313647
41 schema:keywords DNA microarray analysis
42 IIα
43 IIα expression
44 IIα inhibitors
45 NOZ cells
46 Topo IIα
47 Topo IIα expression
48 Topo IIα inhibitors
49 advanced gallbladder carcinoma
50 aim
51 analysis
52 apoptosis
53 approach
54 basis
55 cancer cells
56 carcinoma
57 carcinoma cell lines
58 carcinoma tissue samples
59 cases
60 cell cycle-related genes
61 cell lines
62 cells
63 cellular targets
64 chain reaction
65 chemotherapeutic target
66 cycle-related genes
67 disease
68 doxorubicin
69 effect
70 epithelium
71 etoposide
72 expression
73 gallbladder cancer cells
74 gallbladder carcinoma
75 gallbladder carcinoma cell line
76 gallbladder epithelium
77 gemcitabine
78 gemicitabine
79 genes
80 growth inhibition
81 growth inhibitory effects
82 idarubicin
83 independent samples
84 index
85 induced apoptosis
86 inhibition
87 inhibitors
88 inhibitory effect
89 labeling index
90 lack
91 lines
92 metabolism-related genes
93 microarray analysis
94 molecules
95 normal gallbladder epithelium
96 options
97 potential chemotherapeutic target
98 prognosis
99 quantitative real-time reverse transcription-polymerase chain reaction
100 reaction
101 real-time reverse transcription-polymerase chain reaction
102 resection results
103 results
104 reverse transcription-polymerase chain reaction
105 samples
106 study
107 surgical resection results
108 target
109 therapeutic approaches
110 tissue samples
111 topoisomerase IIα
112 topoisomerase IIα expression
113 transcription-polymerase chain reaction
114 treatment options
115 unfavourable prognosis
116 upregulated genes
117 upregulation
118 schema:name Upregulation of topoisomerase IIα expression in advanced gallbladder carcinoma: a potential chemotherapeutic target
119 schema:pagination 793-801
120 schema:productId N2c8c29a6a74b4e459b54d376550769b6
121 N4377b53e003d4a6b8e17951c946ef980
122 Nc081f560de1d462688398545b25eb5c3
123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007809517
124 https://doi.org/10.1007/s00432-007-0348-0
125 schema:sdDatePublished 2022-10-01T06:35
126 schema:sdLicense https://scigraph.springernature.com/explorer/license/
127 schema:sdPublisher Nfee1c7cbc5fa439ca54df6a6e4ad01fc
128 schema:url https://doi.org/10.1007/s00432-007-0348-0
129 sgo:license sg:explorer/license/
130 sgo:sdDataset articles
131 rdf:type schema:ScholarlyArticle
132 N08e5f24b53ac48938af0b000248f79c3 rdf:first sg:person.01127754745.32
133 rdf:rest Nf434965941ab4438afe373088b50f195
134 N0995c870008d494f92f2e535af4589f5 rdf:first sg:person.016423226454.74
135 rdf:rest Nd488e6ce27ba47fab1495ac1f4fd6a6b
136 N0cdb6efdeef54dcb90839b3e927bcccd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Antineoplastic Agents
138 rdf:type schema:DefinedTerm
139 N1fb39f914c194e7fbba662e2ada3c0ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Gene Expression Profiling
141 rdf:type schema:DefinedTerm
142 N2100a738124c40a8bb19c1cef7ea58d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Doxorubicin
144 rdf:type schema:DefinedTerm
145 N2c8c29a6a74b4e459b54d376550769b6 schema:name doi
146 schema:value 10.1007/s00432-007-0348-0
147 rdf:type schema:PropertyValue
148 N339f9fcc3af64c44830d301341231a67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antigens, Neoplasm
150 rdf:type schema:DefinedTerm
151 N4377b53e003d4a6b8e17951c946ef980 schema:name dimensions_id
152 schema:value pub.1007809517
153 rdf:type schema:PropertyValue
154 N481212cb83304d679cc8f11e514f0489 schema:issueNumber 7
155 rdf:type schema:PublicationIssue
156 N482953226bb1495da462e9b58f3e5b2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Humans
158 rdf:type schema:DefinedTerm
159 N4942ca52192f44c5903154749397cfad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Male
161 rdf:type schema:DefinedTerm
162 N5221e52cd56b4c57836034a438e07ea5 schema:volumeNumber 134
163 rdf:type schema:PublicationVolume
164 N7100ec9c17d249e78706d6e741974027 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Cell Proliferation
166 rdf:type schema:DefinedTerm
167 N77d81251552c4412b335c899032956a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name DNA Topoisomerases, Type II
169 rdf:type schema:DefinedTerm
170 N7b0cb2f6b7254ae8ae8f3339c6390249 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Immunohistochemistry
172 rdf:type schema:DefinedTerm
173 N8f07a3d5e52d493c8db913b9fe4120de rdf:first sg:person.0777733357.02
174 rdf:rest Nc633218866234990815139de7acaebf8
175 N9209d012e3f44c8482ceb377bdbe563a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Biomarkers, Tumor
177 rdf:type schema:DefinedTerm
178 N9404bf47fe394364906098d32baf53a5 rdf:first sg:person.0773025611.35
179 rdf:rest rdf:nil
180 N9830dccc6d6149f89b8ae2e465156625 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Carcinoma
182 rdf:type schema:DefinedTerm
183 N9a5c47ad027748af8a5f55e02247178b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Oligonucleotide Array Sequence Analysis
185 rdf:type schema:DefinedTerm
186 Na660a6d6a6d04bb49b7d46b2721372fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name DNA-Binding Proteins
188 rdf:type schema:DefinedTerm
189 Na7b41ea35a49445cb0543e23c03407d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Blotting, Western
191 rdf:type schema:DefinedTerm
192 Nc081f560de1d462688398545b25eb5c3 schema:name pubmed_id
193 schema:value 18204862
194 rdf:type schema:PropertyValue
195 Nc633218866234990815139de7acaebf8 rdf:first sg:person.0653527253.30
196 rdf:rest N08e5f24b53ac48938af0b000248f79c3
197 Ncb6e4b40353f417e8c40f5a2389bf162 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Gallbladder Neoplasms
199 rdf:type schema:DefinedTerm
200 Ncdd0c8f204a145e6b23938b569379f92 rdf:first sg:person.0673163715.95
201 rdf:rest N9404bf47fe394364906098d32baf53a5
202 Nd035cb41fc664b628b0916debfc79005 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Reverse Transcriptase Polymerase Chain Reaction
204 rdf:type schema:DefinedTerm
205 Nd2cbf7cc894045439ab057d0b6a34cec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Female
207 rdf:type schema:DefinedTerm
208 Nd488e6ce27ba47fab1495ac1f4fd6a6b rdf:first sg:person.01106240505.59
209 rdf:rest Ncdd0c8f204a145e6b23938b569379f92
210 Nd60cf22803494a48905e066fffdb2924 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Up-Regulation
212 rdf:type schema:DefinedTerm
213 Nd974780a381f49e8a42f800cdd7c0ddb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Apoptosis
215 rdf:type schema:DefinedTerm
216 Ndc33932dfc0844b3aaf701eab3137df6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name RNA, Messenger
218 rdf:type schema:DefinedTerm
219 Ne867ca78eeb049578b44c76581a47865 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Etoposide
221 rdf:type schema:DefinedTerm
222 Nef9fc8e3f73f40319162d8d5a748da0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Deoxycytidine
224 rdf:type schema:DefinedTerm
225 Nf14ce050409a4ae4843abe7eff2d37a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Idarubicin
227 rdf:type schema:DefinedTerm
228 Nf434965941ab4438afe373088b50f195 rdf:first sg:person.01103413111.45
229 rdf:rest N0995c870008d494f92f2e535af4589f5
230 Nf69060a32a82453a8aa3adc36b2b5922 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
231 schema:name Gene Expression
232 rdf:type schema:DefinedTerm
233 Nf8b8603ce732486dbc9845d327c35a47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
234 schema:name Aged
235 rdf:type schema:DefinedTerm
236 Nfee1c7cbc5fa439ca54df6a6e4ad01fc schema:name Springer Nature - SN SciGraph project
237 rdf:type schema:Organization
238 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
239 schema:name Medical and Health Sciences
240 rdf:type schema:DefinedTerm
241 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
242 schema:name Oncology and Carcinogenesis
243 rdf:type schema:DefinedTerm
244 sg:journal.1313647 schema:issn 0171-5216
245 1432-1335
246 schema:name Journal of Cancer Research and Clinical Oncology
247 schema:publisher Springer Nature
248 rdf:type schema:Periodical
249 sg:person.01103413111.45 schema:affiliation grid-institutes:grid.136304.3
250 schema:familyName Shimizu
251 schema:givenName Hiroaki
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103413111.45
253 rdf:type schema:Person
254 sg:person.01106240505.59 schema:affiliation grid-institutes:grid.417547.4
255 schema:familyName Sugimoto
256 schema:givenName Takashi
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106240505.59
258 rdf:type schema:Person
259 sg:person.01127754745.32 schema:affiliation grid-institutes:grid.136304.3
260 schema:familyName Kimura
261 schema:givenName Fumio
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127754745.32
263 rdf:type schema:Person
264 sg:person.016423226454.74 schema:affiliation grid-institutes:grid.136304.3
265 schema:familyName Yoshidome
266 schema:givenName Hiroyuki
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016423226454.74
268 rdf:type schema:Person
269 sg:person.0653527253.30 schema:affiliation grid-institutes:grid.136304.3
270 schema:familyName Ohtsuka
271 schema:givenName Masayuki
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653527253.30
273 rdf:type schema:Person
274 sg:person.0673163715.95 schema:affiliation grid-institutes:grid.136304.3
275 schema:familyName Seki
276 schema:givenName Naohiko
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673163715.95
278 rdf:type schema:Person
279 sg:person.0773025611.35 schema:affiliation grid-institutes:grid.136304.3
280 schema:familyName Miyazaki
281 schema:givenName Masaru
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773025611.35
283 rdf:type schema:Person
284 sg:person.0777733357.02 schema:affiliation grid-institutes:grid.136304.3
285 schema:familyName Washiro
286 schema:givenName Mitsutsune
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777733357.02
288 rdf:type schema:Person
289 sg:pub.10.1007/s005340100021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043249581
290 https://doi.org/10.1007/s005340100021
291 rdf:type schema:CreativeWork
292 sg:pub.10.1007/s10495-005-1898-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048856830
293 https://doi.org/10.1007/s10495-005-1898-8
294 rdf:type schema:CreativeWork
295 sg:pub.10.1038/sj.bjc.6601185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025939800
296 https://doi.org/10.1038/sj.bjc.6601185
297 rdf:type schema:CreativeWork
298 sg:pub.10.1038/sj.onc.1205020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020268233
299 https://doi.org/10.1038/sj.onc.1205020
300 rdf:type schema:CreativeWork
301 grid-institutes:grid.136304.3 schema:alternateName Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan
302 Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan
303 schema:name Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan
304 Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoh-ku, 260-8670, Chiba, Japan
305 rdf:type schema:Organization
306 grid-institutes:grid.417547.4 schema:alternateName Department of Life Science Products, Hitachi Software Engineering Co. Ltd., 1-1-43 Suehiro, Tsurumi-ku, 230-0045, Yokohama, Japan
307 schema:name Department of Life Science Products, Hitachi Software Engineering Co. Ltd., 1-1-43 Suehiro, Tsurumi-ku, 230-0045, Yokohama, Japan
308 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...